Complex I Controls Mitochondrial and Plasma Membrane Potentials in Nerve Terminals
- PMID: 32130629
- DOI: 10.1007/s11064-020-02990-8
Complex I Controls Mitochondrial and Plasma Membrane Potentials in Nerve Terminals
Abstract
Reductions in the activities of mitochondrial electron transport chain (ETC) enzymes have been implicated in the pathogenesis of numerous chronic neurodegenerative disorders. Maintenance of the mitochondrial membrane potential (Δψm) is a primary function of these enzyme complexes, and is essential for ATP production and neuronal survival. We examined the effects of inhibition of mitochondrial ETC complexes I, II/III, III and IV activities by titrations of respective inhibitors on Δψm in synaptosomal mitochondria. Small perturbations in the activity of complex I, brought about by low concentrations of rotenone (1-50 nM), caused depolarisation of Δψm. Small decreases in complex I activity caused an immediate and partial Δψm depolarisation, whereas inhibition of complex II/III activity by more than 70% with antimycin A was required to affect Δψm. A similarly high threshold of inhibition was found when complex III was inhibited with myxothiazol, and inhibition of complex IV by more than 90% with KCN was required. The plasma membrane potential (Δψp) had a complex I inhibition threshold of 40% whereas complex III and IV had to be inhibited by more than 90% before changes in Δψp were registered. These data indicate that in synaptosomes, both Δψm and Δψp are more susceptible to reductions in complex I activity than reductions in the other ETC complexes. These findings may be of relevance to the mechanism of neuronal cell death in Parkinson's disease in particular, where such reductions in complex I activity are present.
Keywords: Complex I; Energy thresholds; Membrane potentials; Mitochondria; Nerve terminal; Neurodegeneration.
Similar articles
-
Decylubiquinone increases mitochondrial function in synaptosomes.J Biol Chem. 2010 Mar 19;285(12):8639-45. doi: 10.1074/jbc.M109.079780. Epub 2010 Jan 14. J Biol Chem. 2010. PMID: 20080966 Free PMC article.
-
The production of reactive oxygen species in intact isolated nerve terminals is independent of the mitochondrial membrane potential.Neurochem Res. 2003 Oct;28(10):1575-81. doi: 10.1023/a:1025634728227. Neurochem Res. 2003. PMID: 14570403
-
The respiratory chain complex thresholds in mitochondria of a Drosophila subobscura mutant strain.Biochimie. 2002 Dec;84(12):1189-97. doi: 10.1016/s0300-9084(02)00038-x. Biochimie. 2002. PMID: 12628295
-
Threshold effects and control of oxidative phosphorylation in nonsynaptic rat brain mitochondria.J Neurochem. 1996 Apr;66(4):1617-24. doi: 10.1046/j.1471-4159.1996.66041617.x. J Neurochem. 1996. PMID: 8627318
-
Mitochondrial membrane potential.Anal Biochem. 2018 Jul 1;552:50-59. doi: 10.1016/j.ab.2017.07.009. Epub 2017 Jul 12. Anal Biochem. 2018. PMID: 28711444 Free PMC article. Review.
Cited by
-
A Highly Selective In Vitro JNK3 Inhibitor, FMU200, Restores Mitochondrial Membrane Potential and Reduces Oxidative Stress and Apoptosis in SH-SY5Y Cells.Int J Mol Sci. 2021 Apr 2;22(7):3701. doi: 10.3390/ijms22073701. Int J Mol Sci. 2021. PMID: 33918172 Free PMC article.
-
On the Mechanism of Sustained Mitochondrial Membrane Potential Without Functioning Complex IV.Adv Exp Med Biol. 2022;1395:367-372. doi: 10.1007/978-3-031-14190-4_60. Adv Exp Med Biol. 2022. PMID: 36527664
-
810-nm Photobiomodulation Evokes Glutamate Release in Normal and Rotenone-Dysfunctional Cortical Nerve Terminals by Modulating Mitochondrial Energy Metabolism.Cells. 2025 Jan 7;14(2):67. doi: 10.3390/cells14020067. Cells. 2025. PMID: 39851493 Free PMC article.
-
SRSF1 Is Required for Mitochondrial Homeostasis and Thermogenic Function in Brown Adipocytes Through its Control of Ndufs3 Splicing.Adv Sci (Weinh). 2024 Jun;11(21):e2306871. doi: 10.1002/advs.202306871. Epub 2024 Apr 3. Adv Sci (Weinh). 2024. PMID: 38569495 Free PMC article.
-
Preventing Axonal Sodium Overload or Mitochondrial Calcium Uptake Protects Axonal Mitochondria from Oxidative Stress-Induced Alterations.Oxid Med Cell Longev. 2022 May 24;2022:6125711. doi: 10.1155/2022/6125711. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35663200 Free PMC article.
References
-
- Hornykiewicz O, Kish SJ (1987) Biochemical pathophysiology of Parkinson's disease. Adv Neurol 45:19–34 - PubMed
-
- Kish SJ et al (1992) Brain cytochrome oxidase in Alzheimer’s disease. J Neurochem 59(2):776–779 - PubMed
-
- Schapira AH et al (1990) Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 54(3):823–827 - PubMed
-
- Schapira AH et al (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1(8649):1269 - PubMed
-
- Parker WD Jr, Parks JK, Swerdlow RH (2008) Complex I deficiency in Parkinson’s disease frontal cortex. Brain Res 1189:215–218 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources